MANNKIND CORP Proceeds from Long-term Lines of Credit
MANNKIND CORP (MNKD) reported Proceeds from Long-term Lines of Credit of $4.22 million for the 283-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2014-11-10
- 2014-09-30: .
- 2014-06-30: .
- 2014-03-31: .
- 2013-12-31: .
| Period end | Proceeds from Long-term Lines of Credit 244 month | Proceeds from Long-term Lines of Credit 247 month | Proceeds from Long-term Lines of Credit 250 month | Proceeds from Long-term Lines of Credit 253 month | Proceeds from Long-term Lines of Credit 256 month | Proceeds from Long-term Lines of Credit 259 month | Proceeds from Long-term Lines of Credit 263 month | Proceeds from Long-term Lines of Credit 265 month | Proceeds from Long-term Lines of Credit 268 month | Proceeds from Long-term Lines of Credit 271 month | Proceeds from Long-term Lines of Credit 275 month | Proceeds from Long-term Lines of Credit 277 month | Proceeds from Long-term Lines of Credit 280 month | Proceeds from Long-term Lines of Credit 283 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $4.22M 10-Q · filed 2014-11-10 | |||||||||||||
| 2014-06-30 | $4.22M 10-Q · filed 2014-08-11 | |||||||||||||
| 2014-03-31 | $4.22M 10-Q · filed 2014-05-12 | |||||||||||||
| 2013-12-31 | $4.22M 10-K · filed 2014-03-03 | |||||||||||||
| 2013-09-30 | $4.22M 10-Q · filed 2013-11-12 | |||||||||||||
| 2013-06-30 | $4.22M 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | $4.22M 10-Q · filed 2013-05-10 | |||||||||||||
| 2012-12-31 | $4.22M 10-K · filed 2013-03-18 | |||||||||||||
| 2012-09-30 | $4.22M 10-Q · filed 2012-11-09 | |||||||||||||
| 2012-06-30 | $4.22M 10-Q · filed 2012-08-09 | |||||||||||||
| 2012-03-31 | $4.22M 10-Q · filed 2012-05-10 | |||||||||||||
| 2011-12-31 | $4.22M 10-K · filed 2012-03-15 | |||||||||||||
| 2011-09-30 | $4.22M 10-Q · filed 2011-11-04 | |||||||||||||
| 2011-06-30 | $4.22M 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |